Title : Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease.

Pub. Date : 2019 Mar

PMID : 30906861






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Although short-term treatment with irreversible MAO-B inhibitors, such as selegiline, improves cognitive deficits in AD patients, long-term treatments have shown disappointing results. Selegiline monoamine oxidase B Homo sapiens